CARDIOLOGY PROCEDURES

CARDIOLOGY PROCEDURES

CAT Cardio02

LEFT-RIGHT CARDIAC SHORT CIRCUIT SCINTIGRAPHY

SHUNTS QUANTIFICATION

FIRST-PASS ISOTOPE VENTRICULOGRAPHY

DESCRIPTION

Study of the arrival of a radioactive tracer to the heart and lungs through central circulation. 

PREPARATION

No preparation is required.

INDICATIONS

  • Evaluation of left-right shunts.
  • Diagnosis, quantification and monitoring of heart short circuits.
  • Evaluation of left and right ventricular function.

DURATION OF
PROCEDURE

45 seconds to 15 minutes

LEFT-RIGHT CARDIAC SHORT CIRCUIT SCINTIGRAPHY

SHUNTS QUANTIFICATION

FIRST-PASS ISOTOPE VENTRICULOGRAPHY

DESCRIPTION

Study of the arrival of a radioactive tracer to the heart and lungs through central circulation. 

PREPARATION

No preparation is required.

INDICATIONS

  • Evaluation of left-right shunts.
  • Diagnosis, quantification and monitoring of heart short circuits.
  • Evaluation of left and right ventricular function.

DURATION OF PROCEDURE

45 seconds to 15 minutes.

CAT cardio01

PYROPHOSPHATE CARDIAC TOMOSCINTIGRAPHY (SPET)

PYROPHOSPHATE CARDIAC SCINTIGRAPHY

DESCRIPTION

Assessment of acute myocardial damage.

PREPARATION

  • Good hydration from the moment of administration of the dose until detection (2-3 hours). No fasting required.
  • The maximum sensitivity interval is between the second and fifth days after the acute episode.

INDICATIONS

  • Diagnosis of cardiac infarction in situations where the usual procedures have limited efficacy (infarction without Q wave, preoperative, driving disorders).
  • Predictive cardiac infarction information (VD involvement, location, size).
  • Diagnosis of infectious myocardiopathies: amyloidosis and scleroderma.

DURATION OF
PROCEDURE

3 hours.

PYROPHOSPHATE CARDIAC TOMOSCINTIGRAPHY (SPET)

PYROPHOSPHATE CARDIAC SCINTIGRAPHY

DESCRIPTION

Assessment of acute myocardial damage.

PREPARATION

  • Good hydration from the moment of administration of the dose until detection (2-3 hours). No fasting required.
  • The maximum sensitivity interval is between the second and fifth days after the acute episode.

INDICATIONS

  • Diagnosis of cardiac infarction in situations where the usual procedures have limited efficacy (infarction without Q wave, preoperative, driving disorders).
  • Predictive cardiac infarction information (VD involvement, location, size).
  • Diagnosis of infectious myocardiopathies: amyloidosis and scleroderma.

DURATION OF PROCEDURE

3 hours.

CAT cardio03

123I-MIBG CARDIAC INNERVATION SCINTIGRAPHY

CARDIAC INNERVATION TOMOSCINTIGRAPHY (SPET/SPET-CT)

DESCRIPTION

Study of sympathetic adrenergic activity.

PREPARATION

Blocking of the thyroid gland with 20 drops of potassium iodide, 45-60 minutes before tracer injection.

INDICATIONS

Study of sympathetic adrenergic activity in patients with:

  • Ventricular arrhythmias.
  • Parkinson’s disease.
  • Dementia with Lewy bodies.
  • Diabetic patients.
  • Ischemic heart disease.
  • Cardiac transplants.

DURATION OF
PROCEDURE

5-6 hours.

123I-MIBG CARDIAC INNERVATION SCINTIGRAPHY

CARDIAC INNERVATION TOMOSCINTIGRAPHY (SPET/SPET-CT)

DESCRIPTION

Study of sympathetic adrenergic activity.

PREPARATION

Blocking of the thyroid gland with 20 drops of potassium iodide, 45-60 minutes before tracer injection.

INDICATIONS

Study of sympathetic adrenergic activity in patients with:

  • Ventricular arrhythmias.
  • Parkinson’s disease.
  • Dementia with Lewy bodies.
  • Diabetic patients.
  • Ischemic heart disease.
  • Cardiac transplants.

DURATION OF PROCEDURE

5-6 hours.

CAT cardio05

18F-FDG CARDIAC PET-CT

DESCRIPTION

Study of the metabolism of cardiac glucose, as part of myocardial perfusion studies.

PREPARATION

  • Six-hour fasting required.
  • The patient should not perform intense physical exercise 24 hours before the study.
  • Insulin clamp or glucose oral overload required.

INDICATIONS

Study of myocardial viability.

DURATION OF
PROCEDURE

2 hours.

18F-FDG CARDIAC PET-CT

DESCRIPTION

Study of the metabolism of cardiac glucose, as part of myocardial perfusion studies.

PREPARATION

  • Six-hour fasting required.
  • The patient should not perform intense physical exercise 24 hours before the study.
  • Insulin clamp or glucose oral overload required.

INDICATIONS

Study of myocardial viability.

DURATION OF PROCEDURE

2 hours.

.

CAT Cardio04

STRESS/REST CARDIAC PERFUSION TOMOGRAPHY (SPET) 

STRESS/REST CARDIAC PERFUSION SCINTIGRAPHY

GATED-SPECT CARDIAC PERFUSION TOMOSCINTIGRAPHY

ATTENUATION CORRECTION CARDIAC PERFUSION PET-CT

POST-PHARMACOLOGIC-INTERVENTION DIPYRIDAMOLE, DOBUTAMINE)
CARDIAC PERFUSION TOMOSCINTIGRAPHY (SPET) 

DESCRIPTION

Normal-functional study of myocardial perfusion by intravenous administration of a radiopharmaceutical marked with technetium or thallium to evaluate the alterations of myocardial perfusion (necrosis, viability, ischemia). A cardiologist performs a cardiac stress test with physical exercise (or pharmacological stimulation). The aim is to increase myocardial oxygen consumption through The increase in cardiac overload produced by the realization of a maximum subjective effort test can detect regional reductions in the myocardial flow reserve.

PREPARATION

  • Three-4 hour fasting required.
  • In the case of pharmacological stimulation with dipyridamole, it is essential to avoid the consumption of xanthines (caffeine, theophylline: coffee, Coca Cola, tea) three days before the procedure.
  • Depending on the drug, weight of the patient and the criterion of the nuclear doctor, the stress and rest detection sessions can be done the same day (short protocol) or on different days (long protocol).

INDICATIONS

  • Diagnosis of coronary artery disease and localization of ischemia.
  • Evaluation of post-revascularization myocardial perfusion (ACTP or surgery).
  • Evaluation of myocardial viability.
  • Predictive evaluation of ischemic heart disease.
  • Evaluation of the risk of non-cardiac surgery in the patient with ischemic heart disease.

DURATION OF
PROCEDURE

4 hours.

STRESS/REST CARDIAC PERFUSION TOMOGRAPHY (SPET) 

STRESS/REST CARDIAC PERFUSION SCINTIGRAPHY

GATED-SPECT CARDIAC PERFUSION TOMOSCINTIGRAPHY

ATTENUATION CORRECTION CARDIAC PERFUSION PET-CT

POST-PHARMACOLOGIC-INTERVENTION DIPYRIDAMOLE, DOBUTAMINE)
CARDIAC PERFUSION TOMOSCINTIGRAPHY (SPET) 

DESCRIPTION

Normal-functional study of myocardial perfusion by intravenous administration of a radiopharmaceutical marked with technetium or thallium to evaluate the alterations of myocardial perfusion (necrosis, viability, ischemia). A cardiologist performs a cardiac stress test with physical exercise (or pharmacological stimulation). The aim is to increase myocardial oxygen consumption through The increase in cardiac overload produced by the realization of a maximum subjective effort test can detect regional reductions in the myocardial flow reserve.

PREPARATION

  • Three-4 hour fasting required.
  • In the case of pharmacological stimulation with dipyridamole, it is essential to avoid the consumption of xanthines (caffeine, theophylline: coffee, Coca Cola, tea) three days before the procedure.
  • Depending on the drug, weight of the patient and the criterion of the nuclear doctor, the stress and rest detection sessions can be done the same day (short protocol) or on different days (long protocol).

INDICATIONS

  • Diagnosis of coronary artery disease and localization of ischemia.
  • Evaluation of post-revascularization myocardial perfusion (ACTP or surgery).
  • Evaluation of myocardial viability.
  • Predictive evaluation of ischemic heart disease.
  • Evaluation of the risk of non-cardiac surgery in the patient with ischemic heart disease.

DURATION OF PROCEDURE

4 hours.

CAT cardio06

REST CARDIAC PERFUSION TOMOSCINTIGRAPHY (SPET)

CODES

COMB: 25-3190-PD 20 ● ICS: CR.012 ● CIEP: 92,05 ● SCMN: 33-037-PD 20

DESCRIPTION

Normal-functional study of myocardial perfusion in a base situation by means of the intravenous administration of a radiopharmaceutical marked with technetium or thallium to evaluate the alterations of myocardial perfusion at rest (extension of necrosis and myocardial viability).

PREPARATION

  • No previous preparation is required.
  • It may be necessary to administer sublingual nitrates and to monitor blood pressure.

INDICATIONS

  • Evaluation of the extent of myocardial necrosis.
  • Evaluation of myocardial viability.

DURATION OF
PROCEDURE

Administration-detection time depends on the used radiotracer  (thallium: 3-4 and 24 hours, technetium compounds: 60 minutes).

REST CARDIAC PERFUSION TOMOSCINTIGRAPHY (SPET)

DESCRIPTION

Normal-functional study of myocardial perfusion in a base situation by means of the intravenous administration of a radiopharmaceutical marked with technetium or thallium to evaluate the alterations of myocardial perfusion at rest (extension of necrosis and myocardial viability).

PREPARATION

  • No previous preparation is required.
  • It may be necessary to administer sublingual nitrates and to monitor blood pressure.

INDICATIONS

  • Evaluation of the extent of myocardial necrosis.
  • Evaluation of myocardial viability.

DURATION OF PROCEDURE

Administration-detection time depends on the used radiotracer  (thallium: 3-4 and 24 hours, technetium compounds: 60 minutes).

CAT cardio07

GATED/NON-GATED EQUILIBRIUM ISOTOPE VENTRICULOGRAPHY (STRESS/REST)

POST-PHARMACOLOGIC-INTERVENTION (DOBUTAMINE)
EQUILIBRIUM ISOTOPIC VENTRICULOGRAPHY

DESCRIPTION

Evaluation of blood circulation through the heart and assessment of its pumping and contracting function after physical effort. The systolic and diastolic function of cardiac ventricles is valued, as well as the overall ejection fraction of both ventricles, the regional left one, and the regional contractility. The procedure also allows calculating the ventricular volumes during the effort phase.

PREPARATION

A 4-hour minimum tasting is required.

INDICATIONS

Assessment of the behavior of the left ventricular ejection fraction at rest and the subsequent response to a physical effort, mainly in the diagnosis of coronary artery disease of patients who have suffered a cardiac infarction and for the evolutionary control of patients with aortic insufficiency.

DURATION OF
PROCEDURE

90 minutes.

GATED/NON-GATED EQUILIBRIUM
ISOTOPE VENTRICULOGRAPHY (STRESS/REST)

POST-PHARMACOLOGIC-INTERVENTION (DOBUTAMINE)
EQUILIBRIUM ISOTOPIC VENTRICULOGRAPHY

DESCRIPTION

Evaluation of blood circulation through the heart and assessment of its pumping and contracting function after physical effort. The systolic and diastolic function of cardiac ventricles is valued, as well as the overall ejection fraction of both ventricles, the regional left one, and the regional contractility. The procedure also allows calculating the ventricular volumes during the effort phase.

PREPARATION

A 4-hour minimum tasting is required.

INDICATIONS

Assessment of the behavior of the left ventricular ejection fraction at rest and the subsequent response to a physical effort, mainly in the diagnosis of coronary artery disease of patients who have suffered a cardiac infarction and for the evolutionary control of patients with aortic insufficiency.

DURATION OF PROCEDURE

90 minutes.

CAT cardio08

REST EQUILIBRIUM ISOTOPE VENTRICULOGRAPHY

GATED-SPET ISTOTOPE VENTRICULOGRAPHY

DESCRIPTION

Evaluation of blood circulation through the heart and assessment of its pumping and contracting function IN BASAL SITUATION. The systolic and diastolic function of cardiac ventricles is valued, as well as the overall ejection fraction of both ventricles, regional left one, and the regional contractility. The procedure also allows calculation of ventricular volumes.

PREPARATION

No previous preparation is required.

INDICATIONS

  • Ischemic cardiopathy:

    • DIAGNOSIS: Evaluation of ejection fraction of left ventricle at rest and the existence of alterations of the regional contractility.
    • ACUTE CARDIAC INFARCTION: Stratification of patients according to their functional situation after necrosis by means of:

      • Ejection fraction measurements, being this and VTS the parameters with the highest prognostic value after an infarct.
      • Evaluation of regional contractility: areas of hypokinesia, akinesia or dyskinesia, and detection of right ventricle infarction.
      • Study of ventricular remodeling after necrosis.
  • Valvulopathies: evolutionary control of the function and ventricular volumes.
  • Conduction disorders: Evaluation of ventricular function and description of the myocardial contraction sequence: pacemaker situation, pre-excitation syndromes, ventricular tachycardia.
  • Myocardiopathies:

    • Evolution of the function in myocardial pathology of any etiology.
    • Control of myocardial involvement by chemotherapies (adriamycin).

DURATION OF
PROCEDURE

1 hour.

REST EQUILIBRIUM ISOTOPE VENTRICULOGRAPHY

GATED-SPET ISTOTOPE VENTRICULOGRAPHY

DESCRIPTION

Evaluation of blood circulation through the heart and assessment of its pumping and contracting function IN BASAL SITUATION. The systolic and diastolic function of cardiac ventricles is valued, as well as the overall ejection fraction of both ventricles, regional left one, and the regional contractility. The procedure also allows calculation of ventricular volumes.

PREPARATION

No previous preparation is required.

INDICATIONS

  • Ischemic cardiopathy:

    • DIAGNOSIS: Evaluation of ejection fraction of left ventricle at rest and the existence of alterations of the regional contractility.
    • ACUTE CARDIAC INFARCTION: Stratification of patients according to their functional situation after necrosis by means of:

      • Ejection fraction measurements, being this and VTS the parameters with the highest prognostic value after an infarct.
      • Evaluation of regional contractility: areas of hypokinesia, akinesia or dyskinesia, and detection of right ventricle infarction.
      • Study of ventricular remodeling after necrosis.
  • Valvulopathies: evolutionary control of the function and ventricular volumes.
  • Conduction disorders: Evaluation of ventricular function and description of the myocardial contraction sequence: pacemaker situation, pre-excitation syndromes, ventricular tachycardia.
  • Myocardiopathies:

    • Evolution of the function in myocardial pathology of any etiology.
    • Control of myocardial involvement by chemotherapies (adriamycin).

DURATION OF PROCEDURE

1 hour.

CAT infecto01

18F-FDG PET-CT FOR THE DETECTION OF INFLAMMATORY
AND INFECTIOUS PROCESSES IN CARDIOVASCULAR DEVICES

DESCRIPTION

Detection of heart areas with inflammatory or infectious phenomena.

PREPARATION

  • 6-hour fasting. REVIEW
  • Good hydration.

INDICATIONS

Suspected infection of intravascular devices, pacemakers and catheters.

DURATION OF
PROCEDURE

90 minutes.

18F-FDG PET-CT FOR THE DETECTION OF
INFLAMMATORY AND INFECTIOUS PROCESSES
IN CARDIOVASCULAR DEVICES

DESCRIPTION

Detection of heart areas with inflammatory or infectious phenomena.

PREPARATION

  • 6-hour fasting. REVIEW
  • Good hydration.

INDICATIONS

Suspected infection of intravascular devices, pacemakers and catheters.

DURATION OF PROCEDURE

90 minutes.

Text content

Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
(+34) 93 204 6439, (+34) 93 205 7708 Fax (+34) 93 204 8641 info@simm.barcelona

LogosCalidadJuntos
Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
Phones (+34) 93 204 6439 & (+34) 93 205 7708 Fax (+34) 93 204 8641
E-mail info@simm.barcelona

LogosCalidadJuntos